State Street’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,183,039
Closed -$425M 4295
2025
Q4
$425M Sell
4,183,039
-1,012,242
-19% -$81.3M 0.01% 606
2025
Q3
$284M Sell
5,195,281
-183,746
-3% -$9.18M 0.01% 769
2025
Q2
$286M Sell
5,379,027
-1,234,872
-19% -$62.7M 0.01% 726
2025
Q1
$286M Buy
6,613,899
+381,115
+6% +$19.3M 0.01% 703
2024
Q4
$350M Sell
6,232,784
-447,404
-7% -$27.8M 0.01% 651
2024
Q3
$455M Sell
6,680,188
-1,529,870
-19% -$86.3M 0.02% 560
2024
Q2
$347M Buy
8,210,058
+3,116,411
+61% +$171M 0.02% 614
2024
Q1
$352M Buy
5,093,647
+72,905
+1% +$4.61M 0.02% 627
2023
Q4
$371M Buy
5,020,742
+510,139
+11% +$33.4M 0.02% 584
2023
Q3
$308M Buy
4,510,603
+136,796
+3% +$11.6M 0.02% 596
2023
Q2
$411M Sell
4,373,807
-183,710
-4% -$14.3M 0.02% 547
2023
Q1
$309M Sell
4,557,517
-621,286
-12% -$39.9M 0.02% 612
2022
Q4
$256M Sell
5,178,803
-151,946
-3% -$6.21M 0.02% 663
2022
Q3
$173M Buy
5,330,749
+114,054
+2% +$4.7M 0.01% 780
2022
Q2
$205M Buy
5,216,695
+718,536
+16% +$38.4M 0.01% 731
2022
Q1
$315M Buy
4,498,159
+247,246
+6% +$18.1M 0.02% 662
2021
Q4
$331M Buy
4,250,913
+181,599
+4% +$16M 0.02% 647
2021
Q3
$388M Buy
4,069,314
+196,624
+5% +$20.8M 0.02% 588
2021
Q2
$481M Buy
3,872,690
+532,211
+16% +$63.5M 0.03% 538
2021
Q1
$440M Sell
3,340,479
-121,659
-4% -$16.7M 0.03% 541
2020
Q4
$459M Sell
3,462,138
-156,674
-4% -$18.9M 0.03% 504
2020
Q3
$369M Buy
3,618,812
+9,149
+0.3% +$790K 0.03% 506
2020
Q2
$314M Sell
3,609,663
-231,127
-6% -$18.5M 0.02% 539
2020
Q1
$223M Buy
3,840,790
+94,725
+3% +$7.69M 0.02% 572
2019
Q4
$346M Buy
3,746,065
+519,635
+16% +$45.7M 0.02% 553
2019
Q3
$292M Buy
3,226,430
+185,403
+6% +$21.1M 0.02% 579
2019
Q2
$359M Buy
3,041,027
+739,330
+32% +$74.5M 0.03% 536
2019
Q1
$199M Buy
2,301,697
+56,630
+3% +$4.82M 0.02% 681
2018
Q4
$142M Sell
2,245,067
-103,685
-4% -$7.12M 0.01% 737
2018
Q3
$185M Sell
2,348,752
-183,720
-7% -$12M 0.01% 734
2018
Q2
$151M Sell
2,532,472
-1,202,252
-32% -$64.7M 0.01% 804
2018
Q1
$151M Buy
3,734,724
+207,500
+6% +$10.1M 0.01% 794
2017
Q4
$185M Sell
3,527,224
-567,768
-14% -$30.3M 0.01% 717
2017
Q3
$193M Sell
4,094,992
-71,842
-2% -$2.89M 0.02% 676
2017
Q2
$147M Sell
4,166,834
-485,544
-10% -$15M 0.01% 773
2017
Q1
$110M Sell
4,652,378
-902,614
-16% -$17.9M 0.01% 892
2016
Q4
$74.2M Buy
5,554,992
+582,802
+12% +$9.41M 0.01% 1056
2016
Q3
$92.3M Buy
4,972,190
+2,038,063
+69% +$35.9M 0.01% 924
2016
Q2
$35.9M Sell
2,934,127
-598,849
-17% -$4.51M ﹤0.01% 1342
2016
Q1
$23.8M Sell
3,532,976
-1,596,941
-31% -$10.2M ﹤0.01% 1606
2015
Q4
$47.3M Buy
5,129,917
+2,386,796
+87% +$22.2M 0.01% 1208
2015
Q3
$49.3M Buy
2,743,121
+362,029
+15% +$8.32M 0.01% 1184
2015
Q2
$70.8M Buy
2,381,092
+63,189
+3% +$1.59M 0.01% 1057
2015
Q1
$51M Buy
2,317,903
+379,477
+20% +$9.63M 0.01% 1227
2014
Q4
$53.2M Sell
1,938,426
-124,931
-6% -$3.04M 0.01% 1197
2014
Q3
$40M Sell
2,063,357
-160,317
-7% -$2.94M ﹤0.01% 1290
2014
Q2
$37.9M Sell
2,223,674
-310,291
-12% -$4.27M ﹤0.01% 1374
2014
Q1
$35.9M Buy
2,533,965
+164,767
+7% +$2.23M ﹤0.01% 1394
2013
Q4
$27.7M Sell
2,369,198
-399,716
-14% -$4.59M ﹤0.01% 1527
2013
Q3
$32.7M Buy
2,768,914
+265,015
+11% +$3.4M ﹤0.01% 1402
2013
Q2
$34.8M Buy
+2,503,899
New +$27.2M ﹤0.01% 1309

Other funds holding EXAS

State Street's EXAS Position: Q1 2026 in Review

State Street sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,183,039 shares — an estimated $425M sold.

State Street first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $481M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • State Street reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • State Street sold 4,183,039 Exact Sciences shares in Q1 2026, an estimated $425M.
  • State Street first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • State Street's Exact Sciences position peaked at $481M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.